HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junfeng Shi Selected Research

Biomarkers (Surrogate Marker)

3/2024Plasma Thioredoxin Reductase as a Potential Diagnostic Biomarker for Breast Cancer.
7/2023Thioredoxin reductase as a novel biomarker for the diagnosis and efficacy prediction of gastrointestinal malignancy: a large-scale, retrospective study.
1/2023Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer.
10/2022Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs.
1/2022Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma.
1/2020Integrin-associated CD151 is a suppressor of prostate cancer progression.
7/2019Identification of biomarkers and their functions in dasatinib-resistant pancreatic cancer using bioinformatics analysis.
4/2017Circulating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer.
1/2017Novel insights into circular RNAs in clinical application of carcinomas.
1/2016Nanonets Collect Cancer Secretome from Pericellular Space.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Junfeng Shi Research Topics

Disease

48Neoplasms (Cancer)
04/2024 - 09/2009
12Breast Neoplasms (Breast Cancer)
03/2024 - 06/2012
6Neoplasm Metastasis (Metastasis)
04/2024 - 07/2014
5Inflammation (Inflammations)
10/2023 - 01/2013
5Stomach Neoplasms (Stomach Cancer)
09/2022 - 01/2017
4Stroke (Strokes)
02/2024 - 06/2019
4Insulin Resistance
10/2023 - 03/2014
4Glioma (Gliomas)
01/2022 - 01/2016
4Carcinoma (Carcinomatosis)
01/2021 - 01/2017
3Carcinogenesis
04/2024 - 10/2020
3Wounds and Injuries (Trauma)
10/2023 - 10/2018
3Adenocarcinoma
01/2020 - 06/2018
3Pancreatic Neoplasms (Pancreatic Cancer)
07/2019 - 11/2017
3Glioblastoma (Glioblastoma Multiforme)
01/2018 - 10/2014
2Diarrhea
04/2024 - 08/2023
2Colonic Neoplasms (Colon Cancer)
04/2024 - 10/2022
2Neuroinflammatory Diseases
02/2024 - 10/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2023 - 01/2020
2Lung Neoplasms (Lung Cancer)
08/2023 - 11/2018
2Ovarian Neoplasms (Ovarian Cancer)
03/2023 - 11/2015
2COVID-19
02/2023 - 11/2020
2Obesity
01/2023 - 01/2022
2Triple Negative Breast Neoplasms
12/2020 - 08/2017
2Prostatic Neoplasms (Prostate Cancer)
01/2020 - 06/2018
2Colorectal Neoplasms (Colorectal Cancer)
04/2017 - 01/2017
2Glomerulonephritis
01/2015 - 01/2015
1Enteritis
04/2024
1Metabolic Diseases (Metabolic Disease)
10/2023
1Hyperplasia
10/2023
1Cicatrix (Scar)
10/2023
1Corneal Neovascularization
09/2023
1Fatigue
08/2023
1Paronychia
08/2023
1Mucositis
08/2023
1Hypertension (High Blood Pressure)
08/2023
1Parkinson Disease (Parkinson's Disease)
07/2023
1Hyperglycemia
07/2023

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
04/2024 - 10/2014
11Peptides (Polypeptides)IBA
04/2024 - 10/2015
11Biomarkers (Surrogate Marker)IBA
03/2024 - 01/2014
8HydrogelsIBA
10/2023 - 07/2014
7Messenger RNA (mRNA)IBA
01/2020 - 11/2017
6EnzymesIBA
07/2023 - 10/2015
5MicroRNAs (MicroRNA)IBA
01/2023 - 01/2016
4LigandsIBA
10/2023 - 01/2017
4Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 06/2012
4IntegrinsIBA
12/2020 - 07/2019
3Tumor Biomarkers (Tumor Markers)IBA
03/2024 - 01/2016
3Thioredoxin-Disulfide ReductaseIBA
03/2024 - 01/2023
3empagliflozinIBA
01/2023 - 01/2021
3Long Noncoding RNAIBA
10/2022 - 01/2020
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2020 - 07/2014
2RNA (Ribonucleic Acid)IBA
04/2024 - 01/2017
2MethyltransferasesIBA
04/2024 - 01/2020
2N-methyladenosineIBA
04/2024 - 01/2022
2CytokinesIBA
02/2024 - 01/2023
2Tyrosine Kinase InhibitorsIBA
08/2023 - 07/2019
2Therapeutic UsesIBA
07/2023 - 09/2022
2Sodium-Glucose Transport ProteinsIBA
01/2023 - 01/2021
2Biocompatible Materials (Biomaterials)IBA
08/2022 - 12/2014
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2022 - 12/2021
2CreatinineIBA
06/2021 - 01/2015
2Cadherins (E-Cadherin)IBA
01/2021 - 01/2020
2defactinibIBA
12/2020 - 01/2020
2Receptor Tyrosine Kinase-like Orphan ReceptorsIBA
10/2020 - 01/2020
2Transcription Factors (Transcription Factor)IBA
01/2020 - 01/2019
2DipeptidesIBA
08/2017 - 10/2014
2ElementsIBA
06/2015 - 03/2014
2Sterol Regulatory Element Binding Protein 1IBA
06/2015 - 03/2014
2SterolsIBA
06/2015 - 03/2014
1isoborneol (borneol)IBA
02/2024
1ChemokinesIBA
02/2024
1EdaravoneIBA
02/2024
1AZD4547IBA
01/2024
1WD repeat containing planar cell polarity effectorIBA
10/2023
1Glucose (Dextrose)FDA LinkGeneric
10/2023
1AdipokinesIBA
10/2023
1AntioxidantsIBA
10/2023
1Scavenger Receptors (Scavenger Receptor)IBA
10/2023
1CholesterolIBA
10/2023
1Cell-Penetrating PeptidesIBA
09/2023
1afliberceptIBA
09/2023
1Ophthalmic Solutions (Eye Drops)IBA
09/2023
1Transaminases (Aminotransferases)IBA
08/2023
1ErbB Receptors (EGF Receptor)IBA
08/2023
1anlotinibIBA
08/2023
1amadoriaseIBA
07/2023
1fructosamine-3-kinaseIBA
07/2023
1Glutamine (L-Glutamine)FDA Link
07/2023
1Advanced Glycation End ProductsIBA
07/2023
1Phosphotransferases (Kinase)IBA
03/2023
1tyrosine receptor (receptor, tyrosine)IBA
03/2023
1COVID-19 VaccinesIBA
02/2023
1Nucleic AcidsIBA
02/2023

Therapy/Procedure

30Therapeutics
04/2024 - 01/2013
5Drug Therapy (Chemotherapy)
07/2023 - 08/2017
4Immunotherapy
07/2023 - 06/2018
2Glycemic Control
01/2023 - 03/2019
1Traditional Medicine (Folk Remedies)
04/2024
1Aftercare (After-Treatment)
03/2024